Effect of NMES+ on Hamstring Lesion (3a/3b)

Launched by UNIVERSITÀ DEGLI STUDI DI ROMA FORO ITALICO · Mar 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat hamstring injuries, specifically type 3a/3b strains, which are more severe injuries affecting the hamstring muscle. The treatment involves a technique called NMES+, which uses electrical stimulation along with movement to help heal the injured muscle. The trial aims to find out if this method is effective in improving the recovery of athletes who have experienced this type of injury and whether it helps improve the quality of the muscle tissue.

To be eligible to participate, you should be a recreational or semi-professional athlete between the ages of 18 and 40, with a healthy body weight (BMI between 18.5 and 24.9) and a diagnosed type 3a/3b hamstring strain. Unfortunately, if you have had previous hamstring injuries or certain surgeries, you may not qualify. If you join the trial, you will follow a three-week program that includes specific exercises and NMES+ treatment to support your recovery. This study is still in the planning stage and has not begun recruiting participants yet, but it aims to provide valuable information for better treatment options for hamstring injuries in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • recreational or semi-professional athletes
• • Body Mass Index between 18,5 e 24,9
• • Hamstring strain lesion type 3a/3b
• Exclusion Criteria:
• • previous hamstring strain lesions
• • Anterior Cruciate Ligament Reconstruction using Hamstring graft
• • Current hamstring strains